➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Moodys
McKinsey
Boehringer Ingelheim
AstraZeneca

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

DESOXYN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Desoxyn, and what generic alternatives are available?

Desoxyn is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in DESOXYN is methamphetamine hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

Drug patent expirations by year for DESOXYN
Drug Prices for DESOXYN

See drug prices for DESOXYN

Recent Clinical Trials for DESOXYN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Portland VA Medical CenterPhase 4
Oregon Health and Science UniversityPhase 4
University of California, San FranciscoPhase 4

See all DESOXYN clinical trials

US Patents and Regulatory Information for DESOXYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET;ORAL 005378-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes   Start Trial   Start Trial   Start Trial
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
AstraZeneca
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.